Sort
46,585 grants matching “heart failure”
Genetic modulation of inflammation following myocardial infarction
$770,190Richard J Gumina · Ohio State University · R01 · FY2025 · HL
Identifying Risk Factors for Subclinical Myocardial Disease in HIV Infection
$770,171Katherine C Wu · Johns Hopkins University · R01 · FY2017 · HL
Lung VITamin D and OmegA-3 TriaL (Lung VITAL)
$770,156Diane R Gold · Brigham And Women'S Hospital · R01 · FY2011 · HL
IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - FIELD CENTER - CORE STUDY OPERATIONS
$770,145Thomas H Mosley · University Of Mississippi Med Ctr · N01 · FY2020 · HL
Nighttime Dosing of Anti-Hypertensive Medications: A Pragmatic Clinical Trial
$770,129Gary E Rosenthal · University Of Iowa · UH2 · FY2012 · AT
New mechanisms of heterotaxy and congenital heart disease: nucleoporins at cilia
$770,028Mustafa K Khokha · Yale University · R01 · FY2018 · HL
The impact of Left Ventricular Assist Device Implantation on Cerebral Hemodynamics and Cognition
$769,994Christopher G. Favilla · University Of Pennsylvania · R01 · FY2025 · HL
Comparative effectiveness of anti-obesity medications for cardiometabolic health outcomes and health services use
$769,985Darren Toh · Harvard Pilgrim Health Care, Inc. · R01 · FY2024 · HL
Developing Oral LT3 Therapy for Heart Failure
$769,984Anne R Cappola · University Of Pennsylvania · R33 · FY2020 · HL
Methods for Enhancing Polygenic Risk Prediction Models for Complex Disease
$769,981Dokyoon Kim · University Of Pennsylvania · R01 · FY2025 · HL
Mechanisms of Maladaptation in Heart Failure
$769,926Howard A Rockman · Duke University · R01 · FY2025 · HL
Mechanisms of Maladaptation in Heart Failure
$769,926Howard A Rockman · Duke University · R01 · FY2023 · HL
Adipose tissue mediates cardiac metabolic remodeling in the pathologically stressed heart in the absence of primary metabolic stress
$769,850E Douglas Lewandowski · Ohio State University · R01 · FY2024 · HL
Computational Assessment of Galectin-3 Significance in Heart Failure Remodeling
$769,814Siamak Ardekani · Johns Hopkins University · R01 · FY2016 · HL
Improving Health Outcomes and Equity by Targeting Postpartum Mothers at Highest Risk
$769,772Elizabeth A Howell · University Of Pennsylvania · R01 · FY2024 · MD
Mechanisms of Obesity-induced Atrial Fibrillation
$769,761James C Lo · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · HL
Reagentless Sensor Technologies For Continuous Monitoring of Heart Failure Biomarkers
$769,745Shana O Kelley · Northwestern University · R01 · FY2023 · HL
Oligogenic Models of Cardiomyopathy
$769,729Matthew Neil Bainbridge · Rady Pediatric Genomics & Systems Medicine Institute · R01 · FY2021 · HL
Promoting Kidney Transplantation Tolerance Through Novel Immunomodulation and Cellular Therapy
$769,707Andrew B Adams · University Of Minnesota · U19 · FY2025 · AI
Development of the PTP1B inhibitor MSI-1436 for therapeutic stimulation of heart regeneration following acute myocardial infarction
$769,681Viravuth P Yin · Revidia Therapeutics, Inc · R44 · FY2017 · HL
Angiogenesis and Mechanisms of Exercise Training in PAD
$769,653Duke University · R01 · FY2003 · HL
Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart Failure
$769,564Tamer M A Mohamed · University Of Louisville · R01 · FY2022 · HL
Elucidating Anthracycline-Induced Cell Type-Specific Cardiovascular Toxicity with CRISPRi/a Screens
$769,543Joseph C Wu · Stanford University · R01 · FY2025 · HL
Xenon MRI in Pulmonary Hypertension
$769,506Sudarshan K Rajagopal · Duke University · R01 · FY2022 · HL
Risk stratification in pulmonary arterial hypertension: Intersection of OMICs and longitudinal phenotypes through the PAH Biobank
$769,444William C Nichols · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL